Evogene Market Cap

Evogene has a market cap or net worth of 34.95 million as of October 7, 2025. Its market cap has decreased by -42.09% in one year.

Market Cap

34.95M

Enterprise Value

58.18M

Revenue

31.82M

Ranking

n/a

PE Ratio

n/a

Stock Price

399.00

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 34.95M, a decrease of -69.11%. That is a compound annual growth rate of -6.32%.

Market Cap History

Date	Market Cap	% Change
Oct 5, 2025	34.95M	-26.19%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	74.99B
Danel (Adir Yeoshua)	3.10B
Kamada	1.31B
Bait Bakfar	1.01B
BrainsWay	977.55M
SofWave Medical	960.10M
Ilex Medical	714.47M
Novolog (Pharm-Up 1966)	649.83M

Market Cap Rankings